Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
57 NC counties and 1 VA county are under alert, including Wake, Cumberland, Durham, Johnston, and Orange counties.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Genscript Biotech Corp
(OP:
GNNSF
)
1.050
UNCHANGED
Last Price
Updated: 10:24 AM EDT, Jun 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.050
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
1.050
Today's Range
1.050 - 1.050
52wk Range
1.050 - 3.200
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million
June 08, 2024
Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent...
Via
Talk Markets
3 DNA Stocks to Buy for the Synthetic Biology Revolution
May 14, 2023
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche.
Via
InvestorPlace
Performance
YTD
-49.28%
-49.28%
1 Month
N/A
N/A
3 Month
-31.37%
-31.37%
6 Month
-49.28%
-49.28%
1 Year
-51.16%
-51.16%
More News
Read More
The Next Big Disruptors? 3 Biotech Stocks Making Headlines.
February 17, 2023
Via
InvestorPlace
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
January 21, 2023
Via
Talk Markets
Three Pharma Stocks to Sell Before They Die
December 24, 2022
Via
InvestorPlace
Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact
December 10, 2022
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.